Acrturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/10/22
Arcturus Therapeutics Announces Second Quarter 2022 Financial Update and Pipeline ProgressBusiness Wire • 08/09/22
Arcturus Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 9, 2022Business Wire • 08/01/22
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 06/22/22
Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/10/22
Arcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/09/22
Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline ProgressBusiness Wire • 05/09/22
Arcturus Reports Three-Month Durability Results From ARCT-154 COVID-19 Booster TrialBenzinga • 05/05/22
CORRECTING and REPLACING GRAPHIC Arcturus Reports Strong Three-Month Durability Results from ARCT-154 Booster TrialBusiness Wire • 05/05/22
Arcturus Reports Strong Three-Month Durability Results from ARCT-154 Booster TrialBusiness Wire • 05/05/22
Arcturus Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 9, 2022Business Wire • 04/27/22
Raymond James analyst doesn't expect Arcturus' COVID-19 vaccine to be authorized in the U.S.Market Watch • 04/20/22
Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 StudyBusiness Wire • 04/20/22
Arcturus Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease SummitBusiness Wire • 03/25/22
Piper Comments On Increased Interest To Invest In Arcturus, 'Incrementally Positive' On ArgenxBenzinga • 03/22/22
Arcturus Therapeutics (ARCT) Surges 7.2%: Is This an Indication of Further Gains?Zacks Investment Research • 03/21/22
Arcturus Therapeutics to Participate in the Barclays Global Healthcare ConferenceBusiness Wire • 03/14/22
Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/01/22
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline ProgressBusiness Wire • 02/28/22
Arcturus Therapeutics to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update on February 28, 2022Business Wire • 02/16/22
Arcturus Therapeutics to Participate in the SVB Leerink 11th Annual Global Healthcare ConferenceBusiness Wire • 02/08/22